B
Braidwell Portfolio holdings
AUM
$3.13B
1-Year Est. Return
31.52%
This Fund
S&P 500
1 Year Est. Return
+31.52%
AUM
$3.13B
AUM Growth
-$243M
(-7.2%)
Holding
93
Top Buys
| 1 | +$55.4M | |
| 2 | +$42.4M | |
| 3 | +$40.1M | |
| 4 |
Celldex Therapeutics
CLDX
|
+$33.4M |
| 5 |
Illumina
ILMN
|
+$31.7M |
Top Sells
| 1 | +$74.8M | |
| 2 | +$67M | |
| 3 | +$58.5M | |
| 4 |
Apogee Therapeutics
APGE
|
+$54.4M |
| 5 |
Danaher
DHR
|
+$42M |
Sector Composition
| 1 | Healthcare | 83.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
1
Caris Life Sciences
CAI
$5.68B
| $211M | 6.74% |
7,816,142
+500,000
|
|
||
2
Edgewise Therapeutics
EWTX
$3.22B
| $129M | 4.14% |
5,210,831
|
|
||
3
Neurocrine Biosciences
NBIX
$13.3B
| $107M | 3.41% |
751,534
-128,748
|
|
||
4
Glaukos
GKOS
$6.99B
| $104M | 3.33% |
921,979
+141,815
|
|
||
5
Nuvalent
NUVL
$7.92B
| $82.6M | 2.64% |
821,406
-191,576
|
|
||
6
Xenon Pharmaceuticals
XENE
$3.34B
| $81.8M | 2.62% |
1,825,076
-1,779,953
|
|
||
7
CG Oncology
CGON
$4.86B
| $77.7M | 2.48% |
1,870,571
-1,412,746
|
|
||
|
HNGE
8
Hinge Health
HNGE
$3.37B
| $60.6M | 1.94% |
1,304,623
+394,147
|
|
||
9
Align Technology
ALGN
$13.6B
| $59.5M | 1.9% |
381,004
-28,687
|
|
||
10
Kodiak Sciences
KOD
$1.64B
| $58M | 1.85% |
+2,072,788
|
|
||
11
Soleno Therapeutics
SLNO
$2.1B
| $55M | 1.76% |
1,187,859
-94,130
|
|
||
|
CNTA
12
Centessa Pharmaceuticals
CNTA
$3.97B
| $54.7M | 1.75% |
+2,188,320
|
|
||
13
NeoGenomics
NEO
$1.28B
| $54.5M | 1.74% |
4,632,801
+2,861,655
|
|
||
14
Acadia Pharmaceuticals
ACAD
$4.16B
| $54.3M | 1.74% |
2,032,021
-346,634
|
|
||
15
Spyre Therapeutics
SYRE
$3.38B
| $53.5M | 1.71% |
1,634,615
-943,789
|
|
||
16
Dianthus Therapeutics
DNTH
$2.39B
| $52.5M | 1.68% |
1,273,935
+438,878
|
|
||
|
17
Celldex Therapeutics
CLDX
$2B
| $50.5M | 1.61% |
1,858,109
+1,266,420
|
|
||
18
Inspire Medical Systems
INSP
$1.84B
| $49.9M | 1.6% |
540,890
-342,857
|
|
||
19
Krystal Biotech
KRYS
$8.06B
| $49.8M | 1.59% |
202,101
-318,300
|
|
||
20
Intuitive Surgical
ISRG
$179B
| $47.2M | 1.51% |
83,417
-46,810
|
|
||
21
Thermo Fisher Scientific
TMO
$196B
| $46.8M | 1.5% |
80,725
-33,208
|
|
||
22
BrightSpring Health Services
BTSG
$7.47B
| $44.8M | 1.43% |
+1,195,786
|
|
||
23
CVS Health
CVS
$102B
| $44.8M | 1.43% |
564,200
+125,600
|
|
||
|
24
Apogee Therapeutics
APGE
$4.78B
| $43.4M | 1.39% |
575,067
-863,678
|
|
||
25
Nurix Therapeutics
NRIX
$1.64B
| $41.4M | 1.32% |
+2,183,864
|
|